Pure Red Cell Aplasia - 11 Studies Found Completed : A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment : Pure Red-cell Aplasia : 2005-09-13 : Other: No intervention This is an observational study. No medication will be given to the participants. Completed : A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa : Pure Red-cell Aplasia : 2005-09-13 : Drug: No intervention This study is an observational study. No medication will be provided or administer Completed : A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins : Red-Cell Aplasia, Pure : 2005-09-13 Completed : Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin : Red-Cell Aplasia, Pure Chronic Renal Failure : 2005-09-13 : Other: No Intervention Participants will not receive any intervention in this study. Participants with c Enrolling by invitation : Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa : Red-Cell Aplasia, Pure Renal Insufficiency, Chronic : 2016-01-05 : Procedure: Pure Red Cell Aplasia diagnostic confirmation P Completed : Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure : Pure Red-Cell Aplasia Chronic Kidney Failure : 2006-10-20 Completed : Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease : Anemia Chronic Kidney Disease Chronic Renal Failure < : 2006-04-13 : Drug: peginesatide Other Names: Omontys Hematide AF37 Terminated : Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment : Anti-r-HuEpo Associated PRCA Subjects : 2011-02-01 : Drug: Cyclosporine combine with mycophenolate mofetil Completed : Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders : Neutropenia Sickle Cell Anemia Thalassemia Major : 2000-06-02 : Drug: anti-thymocyte globulin Drug: busulf Completed : Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells : Severe Aplastic Anemia MDS (Myelodysplastic Syndrome) : 2010-07-31 : Device: Miltenyi CD34 Reagent System Other Next >>>
